Abstract
Female dystrophic mice (mdx on C57 Black background) gained weight more rapidly than age-matched controls and had a higher body fat content (% body weight), a slightly lower protein content and a reduced mass of muscle. Chronic treatment (21 d) of the mice with theβ 2-agonist clenbuterol stimulated weight gain in both genotypes without affecting energy intake. Clenbuterol increased the mass of the gastrocnemius and soleus muscle by 13% and 29% in normal and dystrophic mice, respectively, and raised body protein but depressed body fat. Body water and energy content were unaffected by clenbuterol, but the ratio of protein to fat in the carcasses was enhanced by 17% in normal and 56% in dystrophic mice following clenbuterol treatment. Thus, theβ 2-agonist restored the body composition of dystrophic mice to normal and enhanced the protein to fat ratio in both these and normal mice.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baker PK, Dalrymple RH, Ingle DL & Ricks CA (1984) Use of a β-adrenergic agonist to alter muscle and fat deposition in lambs. J. Animal Sci.59, 1256–1261.
Bulfield G, Siller WG, Wight PAL & Moore KJ (1984) X-chromosome linked muscular dystrophy (mdx) in the mouse. Proc. Natl. Acad. Sci. U.S.A.81, 1189–1192.
Cullen MJ & Mastaglia FL (1980) Morphological changes in dystrophic muscle. Br. Med. Bull.36, 145–152.
Dalrymple RH, Ricks CA, Baker PK, Pensack JM, Gingher PE & Ingle DL (1983) Use of the β-agonist clenbuterol to alter carcass composition in poultry. Fed. Proc.42, Abstr. 668.
Emery PW, Rothwell NJ & Stock MJ (1983) Protein synthesis in liver, skeletal muscle and brown adipose tissue of rats fed a protein-deficient diet. Biosci. Rep.3, 569–575.
Emery PW, Rothwell NJ, Stock MJ & Winter PD (1984) Chronic effects ofβ 2-adrenergic agonists on body composition and protein synthesis in the rat. Biosci. Rep.4, 83–91.
Harris JB & Slater CR (1980) Animal models: what is their relevance to the pathogenesis of human muscular dystrophy. Br. Med. Bull.36, 193–197.
Ricks CA, Dalrymple RH, Baker PK & Ingle DL (1983) Use of β-agonist to alter fat and muscle deposition in steers. Fed. Proc. 42, Abstr. 816.
Ricks CA, Baker PK, Dalrymple RH, Doscher ME, Ingle DL & Pankavich J (1984a) Use of clenbuterol to alter muscle and fat accretion in swine. Fed. Proc. 43, Abstr. 857.
Ricks CA, Dalrymple RH, Baker PK and Ingle DL (1984b) Use of a β-agonist to alter fat and muscle deposition in steers. J. Animal Sci.59, 1247–1255.
Rothwell NJ & Stock MJ (1983) Diet-induced thermogenesis. In:Mammalian Thermogenesis (Girardier L & Stock MJ, eds), Chapman & Hall, London, pp 208–233.
Thornton RF, Tume RK, Payne G, Larsen TW, Johnson GW & Hohenhans MA (1985) The influence of theβ 2-adrenergic agonist, clenbuterol, on lipid metabolism and carcass composition of sheep. N.Z. Soc. Animal Prod., in press.
Winter PDO'B (1983) Pharmacological control of thermogenesis and energy balance. PhD thesis, University of London.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rothwell, N.J., Stock, M.J. Mofification of body composition by clenbuterol in normal and dystrophic (mdx) mice. Biosci Rep 5, 755–760 (1985). https://doi.org/10.1007/BF01119873
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01119873